New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2014
07:02 EDTATRSAntares Pharma receives second milestone payment from LEO Pharma
Antares Pharma announced the receipt of a second milestone payment of $5M from LEO Pharma. The milestone payment was received in connection with the launch of OTREXUP and the achievement of a specific percentage of patient lives covered by managed care organizations. To date, Antares has received $10M in milestone payments from LEO Pharma. On November 14, 2013, the company announced an exclusive license and promotion agreement with LEO Pharma for detailing OTREXUP to dermatologists for symptomatic control of severe recalcitrant psoriasis in adults. Under the terms of the agreement, Antares may receive up to a total of $20M in milestone payments. LEO Pharma will be responsible for all promotion and marketing costs in dermatology. Antares Pharma will record all product revenue associated with future dermatology prescriptions and pay LEO Pharma a percentage of OTREXUP net sales generated in dermatology.
News For ATRS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 22, 2014
10:09 EDTATRSOn The Fly: Analyst Initiation Summary
Subscribe for More Information
05:58 EDTATRSAntares Pharma initiated with an Outperform at JMP Securities
Target $4.
October 20, 2014
09:04 EDTATRSAdvanced Cell Technology names LeRoux Jooste as CCO
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use